[
  {
    "ts": null,
    "headline": "DOJ Alleges CVS Knowingly Contributed to Opioid Crisis in Suit",
    "summary": "CVS ignored substantial evidence from multiple sources including its own pharmacists and internal data that indicated its stores were dispensing unlawful prescriptions, the complaint alleges.",
    "url": "https://finnhub.io/api/news?id=ef837cc5b1f160d79975e5da11c04900a3e11599954ed7ccc3fe316c9008b49b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734565200,
      "headline": "DOJ Alleges CVS Knowingly Contributed to Opioid Crisis in Suit",
      "id": 132044547,
      "image": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS ignored substantial evidence from multiple sources including its own pharmacists and internal data that indicated its stores were dispensing unlawful prescriptions, the complaint alleges.",
      "url": "https://finnhub.io/api/news?id=ef837cc5b1f160d79975e5da11c04900a3e11599954ed7ccc3fe316c9008b49b"
    }
  },
  {
    "ts": null,
    "headline": "Feds accuse CVS of facilitating unlawful sale of prescription opioids",
    "summary": "Feds accuse CVS of facilitating unlawful sale of prescription opioids",
    "url": "https://finnhub.io/api/news?id=e1df1d08767476d1d5c45628cd357cdbebd119cb706ab37f27b6166375b8b1af",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734551640,
      "headline": "Feds accuse CVS of facilitating unlawful sale of prescription opioids",
      "id": 132151922,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "Feds accuse CVS of facilitating unlawful sale of prescription opioids",
      "url": "https://finnhub.io/api/news?id=e1df1d08767476d1d5c45628cd357cdbebd119cb706ab37f27b6166375b8b1af"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer’s Bold Take: Why CVS Health (CVS) Is Struggling in Today’s Healthcare Environment",
    "summary": "We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discussed recently. As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street […]",
    "url": "https://finnhub.io/api/news?id=258c543de4e4190056d50813b7c6ad4e9c118c57b241d8ddf1c7395b9cf0b5f3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734551555,
      "headline": "Jim Cramer’s Bold Take: Why CVS Health (CVS) Is Struggling in Today’s Healthcare Environment",
      "id": 132041195,
      "image": "https://s.yimg.com/ny/api/res/1.2/d6hiuhfSWIMOKtD72OdXqQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/4e33e0d1a07889115aefcb74e0ea299f",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discussed recently. As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street […]",
      "url": "https://finnhub.io/api/news?id=258c543de4e4190056d50813b7c6ad4e9c118c57b241d8ddf1c7395b9cf0b5f3"
    }
  },
  {
    "ts": null,
    "headline": "CVS ‘Dangerously’ Understaffed, DOJ Says in Opioid Suit",
    "summary": "CVS ‘Dangerously’ Understaffed, DOJ Says in Opioid Suit",
    "url": "https://finnhub.io/api/news?id=6ad158fb50a661cb3efaf62ff6e015d347c4ce7cf16f9a164066799f662db724",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734540660,
      "headline": "CVS ‘Dangerously’ Understaffed, DOJ Says in Opioid Suit",
      "id": 132151924,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS ‘Dangerously’ Understaffed, DOJ Says in Opioid Suit",
      "url": "https://finnhub.io/api/news?id=6ad158fb50a661cb3efaf62ff6e015d347c4ce7cf16f9a164066799f662db724"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=bbb97d8cdc0ebe01818a8ffa6de429e3cb7707cd30fffc90510579316c6c907b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734540660,
      "headline": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "id": 132151923,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=bbb97d8cdc0ebe01818a8ffa6de429e3cb7707cd30fffc90510579316c6c907b"
    }
  },
  {
    "ts": null,
    "headline": "US healthcare spending rose 7.5% in 2023, government report says",
    "summary": "U.S. healthcare spending rose by 7.5% in 2023 from 4.6% the year prior to reach $4.9 trillion, driven by increased use of medical services and as enrollment climbed for private health plans,...",
    "url": "https://finnhub.io/api/news?id=2e12c319a50de15a1ef32609c8188d7b997e7016e12e202d8bcdc7308e79e780",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734538175,
      "headline": "US healthcare spending rose 7.5% in 2023, government report says",
      "id": 132041475,
      "image": "",
      "related": "CVS",
      "source": "Finnhub",
      "summary": "U.S. healthcare spending rose by 7.5% in 2023 from 4.6% the year prior to reach $4.9 trillion, driven by increased use of medical services and as enrollment climbed for private health plans,...",
      "url": "https://finnhub.io/api/news?id=2e12c319a50de15a1ef32609c8188d7b997e7016e12e202d8bcdc7308e79e780"
    }
  },
  {
    "ts": null,
    "headline": "Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy",
    "summary": "Top 10 Fortune 500 industry leaders show strong yields. See why Energy Transferâs high-dividend, low-price stock stands out as a safer buy in December.",
    "url": "https://finnhub.io/api/news?id=294dcff3250f20a4f41dbf0edac6759822db14a529fa357fbddcf1120756d296",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734531309,
      "headline": "Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy",
      "id": 132040863,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155071595/image_155071595.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Top 10 Fortune 500 industry leaders show strong yields. See why Energy Transferâs high-dividend, low-price stock stands out as a safer buy in December.",
      "url": "https://finnhub.io/api/news?id=294dcff3250f20a4f41dbf0edac6759822db14a529fa357fbddcf1120756d296"
    }
  },
  {
    "ts": null,
    "headline": "Spending Bill Targets Pharmacy Benefit Managers, But Shares Rise Anyhow",
    "summary": "Spending Bill Targets Pharmacy Benefit Managers, But Shares Rise Anyhow",
    "url": "https://finnhub.io/api/news?id=85f552332ed12bd60346eeea30af7c7c8c41dedcae4b43ae7b77c2317f9a76c4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734521700,
      "headline": "Spending Bill Targets Pharmacy Benefit Managers, But Shares Rise Anyhow",
      "id": 132064528,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "Spending Bill Targets Pharmacy Benefit Managers, But Shares Rise Anyhow",
      "url": "https://finnhub.io/api/news?id=85f552332ed12bd60346eeea30af7c7c8c41dedcae4b43ae7b77c2317f9a76c4"
    }
  },
  {
    "ts": null,
    "headline": "Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?",
    "summary": "Cigna and Humana show strong revenue growth, despite recent financial setbacks. Click here to find out why I reaffirm both HUM and CI stocks as buy.",
    "url": "https://finnhub.io/api/news?id=380646abd5b79bb7419e01f158b356dbf40245013216b819fdb01a1cd8ee2fb1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734510600,
      "headline": "Humana, Cigna Plunge On Trump's Latest Promise: A Potential Buying Opportunity?",
      "id": 132038669,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1970763277/image_1970763277.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Cigna and Humana show strong revenue growth, despite recent financial setbacks. Click here to find out why I reaffirm both HUM and CI stocks as buy.",
      "url": "https://finnhub.io/api/news?id=380646abd5b79bb7419e01f158b356dbf40245013216b819fdb01a1cd8ee2fb1"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys",
    "summary": "Financial writer achieves record dividend income in November through investments in BDCs, inching closer to $10,000 annual goal.",
    "url": "https://finnhub.io/api/news?id=1622bfcd6476b1f6935d84f1ad53065555594e875fe18e2d92fb59ae55233c0a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734509400,
      "headline": "My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys",
      "id": 132038523,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Financial writer achieves record dividend income in November through investments in BDCs, inching closer to $10,000 annual goal.",
      "url": "https://finnhub.io/api/news?id=1622bfcd6476b1f6935d84f1ad53065555594e875fe18e2d92fb59ae55233c0a"
    }
  },
  {
    "ts": null,
    "headline": "Bert's November 2024 Dividend Income Summary",
    "summary": "Starbucks has rebounded well, ever since it dropped in the $70s late in 2023 and early 2024. Click to read.",
    "url": "https://finnhub.io/api/news?id=28d0f380a3b1e946c904b4c8f656c0f1206c6e53a3815e59ff9d7398684590da",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734498480,
      "headline": "Bert's November 2024 Dividend Income Summary",
      "id": 132037506,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1830160967/image_1830160967.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "Starbucks has rebounded well, ever since it dropped in the $70s late in 2023 and early 2024. Click to read.",
      "url": "https://finnhub.io/api/news?id=28d0f380a3b1e946c904b4c8f656c0f1206c6e53a3815e59ff9d7398684590da"
    }
  }
]